In this manuscript the authors show that rabbits immunised with the antigen, Tp0751, resulted in attenuated lesion development (moderately convincing), inhibition of T.pallidum dissemination (convincing) and increased cellular infiltration at lesion sites (convincing at the tissue level). There is still an urgent need for a better vaccine for syphilis and this manuscript does make a significant contribution in this area.
However, while some of the findings were convincing at the tissue level, others were less so, as evidenced by comments such as " …difficult to reach a definitive conclusion concerning the true lesion burden …" or "It is likely that both of these proposed mechanisms contributed to the proposed mechanisms …". One aspect that would significantly strengthen the manuscript would be if the authors could link their whole animal and tissue level observations with some underlying immunological mechanisms. While they did observe the broad types of cells at the primary lesion sites, it would have been more useful if they had analysed specific Tp0751 antigen responses in defined T cell types.
The authors also suggest that their positive observation may have been " …suggestive of local production of Tp0751-specific antibodies". Why didn't they measure these antibody levels and perhaps even test for their functional role; neutralisation or binding. By including these additional levels of analyses the study results would be more likely to have interest and impact in the field.
Reviewer #3 (Remarks to the Author):
Summary of the key results The authors have undertaken an experimental model to investigate immunological, clinical, and microbiological correlates of protection against syphilis conferred by a newly developed vaccine. They have found that immunized rabbits have a reduced bacterial load measured by PCR in the organs as compared to unimmunized rabbits, but the vaccine apparently did not provide sterile protection which would be ideal. In the second part of the study, however, the rabbit infectivity testing negative results point towards the desired sterile protection.
Originality and interest:
The claims of the paper are novel and the vaccine may have an important role in mitigation of syphilis complications, but would not work to prevent the disease and ultimately stop transmission. Although the data seems not to be conclusive, the results are most interesting and timely for the development of a fully protective syphilis vaccine.
Data & methodology: -Would the authors consider having used a group of only three animals as a limitation given the discrepant results between animals? -Despite the authors' argument that PCR may have detected dead organisms may be true, the discrepant result for PCR vs microscopic assessment of primary lesions (Rabbit 1) needs to be interpreted with caution. -Could the lower number of Treponema in the inoculation site of Rabbit 3 be related to a decreased proliferation? The current explanation (i.e. greater number of cells migration) seems contradictory to the greater immune cell infiltration in the skin of Rabbit 3.
-qPCR results in Extended Data Table 1 do not seem to correspond to Figure 3 . There might be a typo for the Liver and Spleen Ct1 and Ct2 results: where it says "10 squared" should read "103". Also Liver Im2 seems to have the same mistake. Please confirm since these are the most critical findings of the study. -I would recommend that Extended Table 1 is fitted into the manuscript to facilitate reading comprehension.
-Could the popliteal lymph node for Rabbit 3 have been tested using PCR to confirm the hypothesis of greater load of dead treponemes draining to the lymph node?
Appropriate use of statistics: -Authors may want to revise the statistical analysis of lesions progression (i.e. ulceration and diameter). Currently individual lesions on each rabbit are analyzed as independent items. However, the lesion sites in one rabbit may have correlated results in terms of lesion progression compared to other rabbits. The reason is that lesions in a single rabbit are exposed to the same protective immunity; therefore these are not fully independent units and may need specific statistical methods for comparison (e.g. multilevel model).
Conclusions:
The overall results are very promising but with some contradictions that seem difficult to overcome with a small sample (n=3) study like this, the authors may want to discuss what are the next steps.
It would be good that the researchers explain the path towards development of a syphilis vaccine that can be trialed in humans and possibly to acknowledge certain gaps, including that the current vaccine would not be effective to prevent chancre development and that the current study does not ensure the vaccine is broadly protective against different T pallidum strains.
Clarity and context: -The researchers should more clearly explain why it is important that Tp0751 belongs to the same protein family as the meningococcus b vaccine. If one reads the abstract, as it is currently explained, some people could think that the meningococcus vaccine is protective for syphilis.
-Discrepant results of experiments could be more clearly written -Readers outside the discipline would benefit of a schematic of the main result to accompany publication.
1. "…parts of the Material and Methods need additional information e.g. it is not even introduced which T. pallidum strain has been used to challenge the rabbits. 4. Ideally, animal numbers need to be upgraded. I would say group size must be at least 4-5/group. It looks like some more animals were used for vaccination against tp0751 (e.g., animal Im26 pops-up all over sudden in Supplementary Fig. 2 
